September 12, 2023 – Carbon Medical Technologies, Inc. (CMT), a manufacturer of pyrolytic carbon-coated medical devices used in biopsy procedures, for radiation therapy, and to treat stress urinary incontinence, is proud to announce that it has been awarded the prestigious Export Achievement Certificate by the Under Secretary of Commerce for International Trade, Marisa Lago. This esteemed recognition highlights CMT’s outstanding contributions to the global healthcare industry and its commitment to expanding its reach internationally.
The Export Achievement Certificate, presented by U.S. Commercial Service, is a testament to CMT’s dedication to fostering international trade and promoting American technology abroad. This prestigious honor acknowledges the company’s exceptional accomplishments in exporting its pyrolytic carbon-coated medical devices to markets around the world, including the recent approval of its devices with the Health Sciences Authority in Singapore.
Under Secretary of Commerce for International Trade Marisa Lago praised CMT for its role in advancing solutions that improve healthcare outcomes worldwide. In a statement, Under Secretary Lago said, “We are proud to present Carbon Medical Technologies with the Export Achievement Certificate in recognition of their outstanding contributions to international trade.”
Accepting the Export Achievement Certificate, President & CEO, Stephanie Kent expressed gratitude and shared the company’s vision for the future: “We are honored to receive the Export Achievement Certificate from Under Secretary Marisa Lago and the U.S. Commercial Service team. This recognition underscores our dedication to delivering innovative healthcare solutions to people worldwide. We are committed to expanding our global footprint and contributing to the well-being of communities around the world.” With a focus on quality, innovation, and patient-centric solutions, the company has earned a reputation for excellence both domestically and internationally.
For more information about Carbon Medical Technologies and its innovative medical devices, please visit www.carbonmed.com or contact 1-888-207-0262.
About Carbon Medical Technologies, Inc.
Carbon Medical Technologies, Inc. (CMT) is a privately held company formed in 1994 to design, develop, and manufacture permanent human implantable products utilizing pyrolytic carbon. CMT operates a fully functional pyrolytic carbon coating facility and has developed multiple devices including BiomarC implantable tissue markers developed for biopsy site marking, the BiomarC fiducial marker product line for radiation therapy treatment planning, and an injectable bulking agent called Durasphere, which is used for the treatment of stress urinary incontinence in women, and additional indications outside of the US. CMT also provides product development, contract manufacturing, and regulatory consulting for medical device companies.
The company is a medical device manufacturer with ISO 13485 certified and cGMP compliant quality systems, maintains three sterilization method validations, and does final product assembly and packaging in an ISO Class 7 clean room environment.